Depreciation in USD of Entero Therapeutics, Inc. from Q3 2015 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Entero Therapeutics, Inc. quarterly/annual Depreciation history and change rate from Q3 2015 to Q4 2024.
  • Entero Therapeutics, Inc. Depreciation for the quarter ending 31 Dec 2024 was $286.000, a 96.3% decline year-over-year.
  • Entero Therapeutics, Inc. Depreciation for the twelve months ending 31 Dec 2024 was $14.6K, a 50.2% decline year-over-year.
  • Entero Therapeutics, Inc. annual Depreciation for 2024 was $14.6K, a 50.2% decline from 2023.
  • Entero Therapeutics, Inc. annual Depreciation for 2023 was $29.3K, a 0.01% increase from 2022.
  • Entero Therapeutics, Inc. annual Depreciation for 2022 was $29.3K, a 99% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Entero Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $14.6K $286 -$7.39K -96.3% 01 Oct 2024 31 Dec 2024 10-K/A 09 Apr 2025
Q3 2024 $22K $1K -$6K -85.7% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2024
Q2 2024 $28K $5.5K -$1.8K -24.7% 01 Apr 2024 30 Jun 2024 10-Q 21 Oct 2024
Q1 2024 $29.8K $7.78K +$479 +6.56% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2024
Q4 2023 $29.3K $7.67K 01 Oct 2023 31 Dec 2023 10-K/A 09 Apr 2025
Q3 2023 $7K 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024
Q2 2023 $7.3K 01 Apr 2023 30 Jun 2023 10-Q 21 Oct 2024
Q1 2023 $7.3K -$17 -0.23% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q1 2022 $21K $7.32K +$6.3K +617% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q4 2021 $14.7K $5.69K -$5.45K -48.9% 01 Oct 2021 31 Dec 2021 10-K 20 Mar 2023
Q3 2021 $20.2K $6K -$2K -25% 01 Jul 2021 30 Sep 2021 10-Q/A 16 Nov 2021
Q2 2021 $22.2K $2K -$7K -77.8% 01 Apr 2021 30 Jun 2021 10-Q 16 Aug 2021
Q1 2021 $29.2K $1.02K -$8.64K -89.4% 01 Jan 2021 31 Mar 2021 10-Q 23 May 2022
Q4 2020 $37.8K $11.1K -$699 -5.91% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 $38.5K $8K -$9.22K -53.5% 01 Jul 2020 30 Sep 2020 10-Q/A 16 Nov 2021
Q2 2020 $47.7K $9K -$7.93K -46.8% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021
Q1 2020 $55.6K $9.66K -$7.45K -43.5% 01 Jan 2020 31 Mar 2020 10-Q 24 May 2021
Q4 2019 $63.1K $11.8K -$4K -25.3% 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2021
Q3 2019 $67.1K $17.2K +$1.57K +10% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020
Q2 2019 $65.5K $16.9K +$1.27K +8.11% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020
Q1 2019 $64.3K $17.1K +$2.35K +15.9% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020
Q4 2018 $61.9K $15.8K +$2.17K +15.9% 01 Oct 2018 31 Dec 2018 10-K 30 Mar 2020
Q3 2018 $59.7K $15.7K +$2.93K +23% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 $56.8K $15.7K +$3.13K +25% 01 Apr 2018 30 Jun 2018 10-Q 13 Aug 2019
Q1 2018 $53.7K $14.8K +$4.17K +39.3% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q4 2017 $49.5K $13.7K +$2.46K +22% 01 Oct 2017 31 Dec 2017 10-K 01 Apr 2019
Q3 2017 $47.1K $12.7K +$1.56K +14% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018
Q2 2017 $45.5K $12.5K +$1.44K +13% 01 Apr 2017 30 Jun 2017 10-Q 13 Aug 2018
Q1 2017 $44.1K $10.6K -$248 -2.29% 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018
Q4 2016 $44.3K $11.2K 01 Oct 2016 31 Dec 2016 10-K 16 Mar 2018
Q3 2016 $11.2K +$2.46K +28.3% 01 Jul 2016 30 Sep 2016 10-Q 13 Nov 2017
Q2 2016 $11.1K 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017
Q1 2016 $10.8K 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q3 2015 $8.71K 01 Jul 2015 30 Sep 2015 10-Q 25 Nov 2016

Entero Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $14.6K -$14.7K -50.2% 01 Jan 2024 31 Dec 2024 10-K/A 09 Apr 2025
2023 $29.3K +$3.00 +0.01% 01 Jan 2023 31 Dec 2023 10-K/A 09 Apr 2025
2022 $29.3K +$14.6K +99% 01 Jan 2022 31 Dec 2022 10-K 29 Mar 2024
2021 $14.7K -$23.1K -61.1% 01 Jan 2021 31 Dec 2021 10-K 20 Mar 2023
2020 $37.8K -$25.3K -40.1% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2019 $63.1K +$1.19K +1.92% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021
2018 $61.9K +$12.4K +25% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020
2017 $49.5K +$5.22K +11.8% 01 Jan 2017 31 Dec 2017 10-K 01 Apr 2019
2016 $44.3K +$2.52K +6.03% 01 Jan 2016 31 Dec 2016 10-K 16 Mar 2018
2015 $41.8K 01 Jan 2015 31 Dec 2015 10-K 31 Mar 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.